+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Collection of Pituitary Portal Blood: A Methodologic Analysis


      S. Karger AG

      Luteinizing hormone, Pituitary portal blood, Hypothalamus

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Two methods for the collection of pituitary portal blood were compared. The portal blood aspiration method developed by Worthington and Fink consists of periodically aspirating portal blood as it collects around the transected pituitary stalk. The stalk cannulation method developed by Porter eliminates possible contamination of the sample by extraneous blood by collecting the portal blood into a polyethylene cannula which fits tightly around the stalk. In this study, contamination of portal blood collected by the portal blood aspiration method was identified and quantitated by measuring now rates and LH concentration of blood from the various sources contributing to the collection. Blood collected by the portal blood aspiration method contained 68% pure portal blood, 21% extraneous peripheral blood from damaged tissues, and 11% pituitary blood from the distal end of the transected stalk. The flow rate of pure portal blood was the same in the two methods. Despite the problem of contamination and dilution, the portal blood aspiration method is well suited for measurement of labile substances because the blood can be added to appropriate preservatives within seconds. For the measurement of more stable substances, the stalk cannulation method is preferred.

          Related collections

          Author and article information

          S. Karger AG
          28 March 2008
          : 38
          : 2
          : 97-101
          Department of Reproductive Medicine, School of Medicine, University of California at San Diego, La Jolla, Calif., USA
          123875 Neuroendocrinology 1984;38:97–101
          © 1984 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Original Paper


          Comment on this article